Free database of papers and journals






Results 1 to 13 of 13 articles found
2013

Sildenafil and Exercise Capacity in Heart Failure

JAMA (5.8 726★★★), 310, 432.
2008

Sildenafil and phosphodiesterase-5 inhibitors for heart failure

Current Heart Failure Reports (2.3 45), 5, 110-114.
2007

Long-Term Use of Sildenafil in the Therapeutic Management of Heart Failure

Journal of the American College of Cardiology (1.6 478★★), 50, 2136-2144.
2004

Influences of sildenafil on lung function and hemodynamics in patients with chronic heart failure

Clinical Pharmacology and Therapeutics (4.4 220★★), 76, 371-378.
2017

[Communication] Is sildenafil neutral on cardiopulmonary performance in group 2 pulmonary hypertension? More details for interpretation

European Journal of Heart Failure (8.4 137), 19, 691-691.
2009

Six months of Sildenafil therapy improves heart rate recovery in patients with heart failure

International Journal of Cardiology (2.2 132), 136, 341-343.
2007

Sildenafil reduces L-NAME-induced severe hypertension and worsening of myocardial ischaemia–reperfusion damage in the rat

British Journal of Pharmacology (7.1 242★★), 150, 567-576.
2008

Endothelium-mediated Modulation of Ergoreflex and Improvement in Exercise Ventilation by Acute Sildenafil in Heart Failure Patients

Clinical Pharmacology and Therapeutics (4.4 220★★), 83, 336-341.
2013

Sildenafil in Heart Failure (SilHF). An investigator-initiated multinational randomized controlled clinical trial: rationale and design

European Journal of Heart Failure (8.4 137), 15, 119-122.
2010

Ventilatory efficiency and dyspnea on exertion improvements are related to reduced pulmonary pressure in heart failure patients receiving Sildenafil

International Journal of Cardiology (2.2 132), 144, 410-412.
2004

The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure

Journal of the American College of Cardiology (1.6 478★★), 44, 2339-2348.
2011

PDE5 Inhibition With Sildenafil Improves Left Ventricular Diastolic Function, Cardiac Geometry, and Clinical Status in Patients With Stable Systolic Heart Failure

Circulation Heart Failure (4.7 118), 4, 8-17.
2012

Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study

European Journal of Heart Failure (8.4 137), 14, 82-90.
Anatomy of Results
The left numbers are the publication year, and the number of citations (hyperlink to the full citation report of the paper)
paranthesis after the journal provides its impact factor.
paranthesis after the author indicates the number of publications and Author's Impact Factor
EXALY
Authors
Journals
Institutions